1. Blairon L, De Gheldre Y, Delaere B, Sonet A, Bosly A, Glupczynski Y. A 62-month retrospective epidemiological survey of anaerobic bacteraemia in a university hospital. Clin Microbiol Infect. 2006; 12:527–32.
Article
2. Diekema DJ, Beekmann SE, Chapin KC, Morel KA, Munson E, Doern GV. Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J Clin Microbiol. 2003; 41:3655–60.
Article
3. Park Y, Lee Y, Kim M, Choi JY, Yong D, Jeong SH, et al. Recent trends of anaerobic bacteria isolated from clinical specimens and clinical characteristics of anaerobic bacteremia. Infect Chemother. 2009; 41:216–23.
Article
4. Zahar JR, Farhat H, Chachaty E, Meshaka P, Antoun S, Nitenberg G. Incidence and clinical significance of anaerobic bacteraemia in cancer patients: a 6-year retrospective study. Clin Microbiol Infect. 2005; 11:724–9.
Article
5. Wilson JR and Limaye AP. Risk factors for mortality in patients with anaerobic bacteremia. Eur J Clin Microbiol Infect Dis. 2004; 23:310–6.
6. Decousser JW, Bartizel C, Zamni M, Fadel N, Doucet-Populaire F. Clostridium symbiosum as a cause of bloodstream infection in an immunocompetent patient. Anaerobe. 2007; 13:166–9.
7. Elsayed S and Zhang K. Bacteremia caused by Clostridium symbiosum. J Clin Microbiol. 2004; 42:4390–2.
8. The Korean Society for Laboratory Medicine. Diagnostic Laboratory Medicine. 4th ed.E Public;2009. p. 497.
9. Johnson MJ, Thatcher E, Cox ME. Techniques for controlling variability in gram staining of obligate anaerobes. J Clin Microbiol. 1995; 33:755–8.
Article
10. Woo PC, Lau SK, Chan KM, Fung AM, Tang BS, Yuen KY. Clostridium bacteraemia characterised by 16S ribosomal RNA gene sequencing. J Clin Pathol. 2005; 58:301–7.
Article